 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Akari Therapeutics Plc (AKTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2015-09-18 Purchase | 2015-09-22 5:42 pm | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 1,055,600 | $0.1895 | $200,036 | 1,055,600 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2015-09-21 Option Award | 2015-09-22 5:41 pm | N/A 2025-09-21 | Akari Therapeutics Plc | AKTX | Roshwalb Gur CEO | 32,543,700 | $0.3221 | 32,543,700 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-22 5:42 pm | N/A 2025-09-21 | Akari Therapeutics Plc | AKTX | Elefant Dov CFO | 4,067,963 | $0.3221 | 4,067,963 (Direct) | View |
| 2015-09-18 Option Award | 2015-09-22 5:42 pm | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 85,000 | $0.3221 | 1,055,600 (Direct) | View |
| 2015-09-18 Option Award | 2015-09-22 5:42 pm | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 186,278 | $0.3221 | 1,055,600 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-23 10:42 am | 2016-09-21 2025-02-21 | Akari Therapeutics Plc | AKTX | Ungar Stuart Director 10% Owner | 211,278 | $0.3221 | 211,278 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-23 10:43 am | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Richardson Clive COO | 16,271,850 | $0.3221 | 16,271,850 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-23 10:44 am | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Hill James Director 10% Owner | 231,278 | $0.3221 | 231,278 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-23 5:11 pm | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Shaw Allan Director | 45,000 | $0.3221 | 186,278 (Direct) | View |
| 2015-09-21 Option Award | 2015-09-23 5:11 pm | 2016-09-21 2025-09-21 | Akari Therapeutics Plc | AKTX | Shaw Allan Director | 186,278 | $0.3221 | 186,278 (Direct) | View |
| 2015-11-25 Option Award | 2015-11-25 6:57 pm | 2016-11-25 2025-11-25 | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 1,028,722 | $0.1917 | 1,028,722 (Direct) | View |
| 2015-11-25 Option Award | 2015-11-25 6:57 pm | 2016-11-25 2025-11-25 | Akari Therapeutics Plc | AKTX | Shaw Allan Director | 1,068,722 | $0.1917 | 1,068,722 (Direct) | View |
| 2015-11-25 Option Award | 2015-11-25 6:58 pm | 2016-11-25 2025-11-25 | Akari Therapeutics Plc | AKTX | Hill James Director | 1,068,722 | $0.1917 | 1,068,722 (Direct) | View |
| 2015-11-25 Option Award | 2015-11-25 6:58 pm | 2016-11-25 2025-11-25 | Akari Therapeutics Plc | AKTX | Ungar Stuart Director | 1,088,722 | $0.1917 | 1,088,722 (Direct) | View |
| 2016-03-23 Option Award | 2016-03-25 4:16 pm | 2016-03-23 2026-03-23 | Akari Therapeutics Plc | AKTX | SHAW ROBERT M General Counsel and Secretary | 1,800,000 | $14.1 | 1,800,000 (Direct) | View |
| 2016-04-22 Option Award | 2016-04-26 4:31 pm | 2017-04-22 2026-04-22 | Akari Therapeutics Plc | AKTX | Byrne David Director | 1,300,000 | $17.96 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:08 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Williams Donald Allen Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:08 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Williams Donald Allen Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:09 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Ungar Stuart Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:10 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Hill James Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:10 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Byrne David Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |
| 2016-06-29 Option Award | 2016-06-30 5:11 pm | N/A 2026-06-29 | Akari Therapeutics Plc | AKTX | Cohen Mark S Director | 1,300,000 | $0.1454 | 1,300,000 (Direct) | View |